Basic | |
---|---|
Market Cap | $101.61B |
Price | $53.1 |
52 Week Range | 39.35-58.46 |
Beta | 0.46 |
Margins | |
Gross Profit Margin | 70.79% |
Operating Profit Margin | 26.56% |
Net Profit Margin | -14.06% |
Valuation (TTM) | |
P/E Ratio | -16.15 |
Price to Sales Ratio | 2.27 |
Price to Book Ratio | 6.21 |
PEG Ratio | 3.12 |
Drug Manufacturers - General
Healthcare
34,100
1972-06-01T00:00:00.000Z
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.
212 546 4000
430 East 29th Street, New York, NY, 10016, US
0000014272